Status:
COMPLETED
Comparison of Intraperitoneal Bupivacaine Alone or With Dexmedetomidine
Lead Sponsor:
RESnTEC, Institute of Research
Collaborating Sponsors:
Bahawal Victoria Hospital
Conditions:
LAPAROSCOPIC CHOLECYSTECTOMY
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
For patients with symptomatic cholelithiasis, laparoscopic cholecystectomy (LC) is a customary procedure for treatment these days. After LC, patients may experience considerable pain. This study was p...
Eligibility Criteria
Inclusion
- Patients of either gender
- Aged between 20 and 70 years
- ASA (American Society of Anesthesiologists Classification) physical status I and II
- Undergoing Laparoscopic Cholecystectomy under general anesthesia
Exclusion
- Patients sensitive to local anesthetics
- Patients with acute cholecystitis, choledocholithiasis, or ascending cholangitis (temperature≥38.6°C, serum bilirubin≥1.2mg/dl, and ultrasound showing common bile duct diameter of ≥1cm).
- Patients with uncontrolled diabetes (FBS≥110 mg/dl)
- Uncontrolled blood pressure (SBP≥140 mmHg)
- Ischemic heart disease (EF≤40%)
- Pulmonary dysfunction (FEV≤70 percent of normal)
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT06560892
Start Date
January 1 2024
End Date
June 30 2024
Last Update
August 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Quaid-e-Azam Medical College
Bahawalpur, Punjab Province, Pakistan, 06318